conducted a systematic proteomic analysis of stage I to IIIC rectal cancer tissues, revealing significantly upregulated VTN expression levels in metastatic CRC.[39] Despite these insights, research into the role of VTN in CRC remains limited, with most findings derived from small‐scale clinical retrospective cohort studies. The gene discussed is VTN; the disease is rectal cancer.